• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Organisation › Details

bioMérieux (Group)

A world leader in the field of in vitro diagnostics for over 45 years, bioMérieux is present in more than 150 countries through 39 subsidiaries and a large network of distributors. In 2008, revenues reached €1.111 billion with 84% of sales outside of France. bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Our products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the NYSE Euronext Paris market (Symbol: BIM - ISIN: FR0010096479). Other information can be found at www.biomerieux.com. *

 

	Start	1999-09-09 existent
	Group	Mérieux (Group)
	Industry	BIOTECH
	Industry 2	diagnostics (medical/biological)
	Region	Marcy-l’Étoile, Rhône
	Country	France
	City	69280 Marcy l’étoile
	Tel	+33-4-7887-2000
	Fax	+33-4-7887-2090
		Address record changed: 2010-05-09
Basic data	Employees	G: 5,001 to 10,000 (2010-06-30)
	Currency	EUR
	Annual sales	1,223,400,000 (sales, net, consolidated (2009) 2009-12-31)
	Profit	148,200,000 (2009-12-31)
	Cash	47,000,000 (2009-12-31)
		* Document for »About Section«: bioMérieux S.A.. (1/7/10). "Press Release: Philips and bioMérieux Announce Partnership to Develop and Market Next-generation Handheld Diagnostic Solutions for Point-of-Care". Amsterdam & Marcy l’Etoile.
		Record changed: 2011-11-27

More documents for Mérieux (Group)

• [1] bioMérieux S.A.. (6/22/11). "Press Release: bioMérieux Launches Groundbreaking Salmonella Detection Technology to Improve Food Safety". Marcy l’Etoile....
• [2] bioMérieux S.A.. (5/19/11). "Press Release: bioMérieux Becomes the World Leader in Food Testing with AES Laboratoire Acquisition". Marcy l’Etoile....
• [3] bioMérieux S.A.. (5/5/11). "Press Release: bioMérieux and Labor Berlin (Charité Vivantes GmbH) to Establish Center of Excellence in Laboratory Diagnostics". Berlin & Marcy l’Etoile....
• [4] bioMérieux S.A.. (3/8/11). "Press Release: bioMérieux – 2010 Financial Results". Marcy l’Étoile....
• [5] bioMérieux S.A.. (1/19/11). "Press Release: bioMérieux – 2010 Business Review". Marcy l’Étoile....
• [6] bioMérieux S.A.. (9/6/10). "Press Release: First-half 2010 Results". Marcy-l’Étoile....
• [7] bioMérieux S.A.. (7/22/10). "Press Release: First-half 2010 Business Review". Marcy-l’Étoile....
• [8] bioMérieux S.A.. (5/21/10). "Press Release: Shimadzu and bioMérieux Enter into Partnership for Mass Spectrometry Applications in Microbiology". Kyoto & Marcy l’Etoile....
• [9] bioMérieux S.A.. (5/17/10). "Press Release: bioMérieux Strengthens North American Executive Management Team. Manuel Mendez to serve as Executive Vice President, Commercial Operations for bioMérieux Inc.". Marcy l’Étoile....
• [10] bioMérieux S.A.. (4/21/10). "Press Release: bioMérieux and Knome Sign Startegic Partnership". Marcy l’Étoile & Cambridge, MA....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.